Tectonic Therapeutic, Inc.
TECX
$17.08
$1.7211.20%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 20.56M | 19.76M | 16.65M | 14.00M | 10.66M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 74.26M | 63.35M | 58.02M | 53.40M | 43.88M |
Operating Income | -74.26M | -63.35M | -58.02M | -53.40M | -43.88M |
Income Before Tax | -65.00M | -58.67M | -57.98M | -53.48M | -45.82M |
Income Tax Expenses | 976.00K | -- | -- | -- | -- |
Earnings from Continuing Operations | -65.98 | -58.67 | -57.98 | -53.48 | -45.82 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -65.98M | -58.67M | -57.98M | -53.48M | -45.82M |
EBIT | -74.26M | -63.35M | -58.02M | -53.40M | -43.88M |
EBITDA | -72.63M | -61.72M | -56.37M | -51.89M | -42.42M |
EPS Basic | -4.04 | -7.31 | -17.35 | -22.40 | -28.82 |
Normalized Basic EPS | -2.49 | -4.57 | -10.84 | -14.00 | -18.01 |
EPS Diluted | -4.04 | -7.31 | -17.35 | -22.40 | -28.82 |
Normalized Diluted EPS | -2.49 | -4.57 | -10.84 | -14.00 | -18.01 |
Average Basic Shares Outstanding | 65.36M | 49.60M | 33.83M | 20.37M | 6.96M |
Average Diluted Shares Outstanding | 65.36M | 49.60M | 33.83M | 20.37M | 6.96M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |